Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients.

Pharmacokinetic and coagulation studies were carried out over a 12-week period with 11 asymptomatic hemophilia patients with human immunodeficiency virus infection receiving zidovudine (ZDV). The patients received 300 mg every 4 h while awake (the accepted dose at the time of this study); consecutiv...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Morse, G D, Portmore, A C, Marder, V, Plank, C, Olson, J, Taylor, C, Bonnez, W, Reichman, R C
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1992
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245484/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1444306/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.10.2245
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!